Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Breast Cancer

Free Subscription Articles published in Breast Cancer Res Treat Retrieve available abstracts of 508 articles: HTML format

Single Articles

July 2008
1. ECK SM , Hoopes PJ, Petrella BL, Coon CI, et al
   Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model.
   Breast Cancer Res Treat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. KORKMAZ A , Sanchez-Barcelo EJ, Tan DX, Reiter RJ, et al
   Role of melatonin in the epigenetic regulation of breast cancer.
   Breast Cancer Res Treat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. CALABRO A , Beissbarth T, Kuner R, Stojanov M, et al
   Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer.
   Breast Cancer Res Treat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. RAO MV , Shayne M
   Vitiligo in the affected breast during neo-adjuvant chemotherapy for breast cancer.
   Breast Cancer Res Treat. 2008;.
   PubMed     Related articles   
   
   
   
5. JONES RL , Salter J, A'hern R, Nerurkar A, et al
   The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer.
   Breast Cancer Res Treat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   June 2008
6. GAPSKA P , Scott RJ, Serrano-Fernandez P, Huzarski T, et al
   Vitamin D receptor variants and breast cancer risk in the Polish population.
   Breast Cancer Res Treat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. COTICCHIA CM , Revankar CM, Deb TB, Dickson RB, et al
   Calmodulin modulates Akt activity in human breast cancer cell lines.
   Breast Cancer Res Treat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. TURASHVILI G , McKinney S, Martin L, Gelmon KA, et al
   Columnar cell lesions, mammographic density and breast cancer risk.
   Breast Cancer Res Treat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. BAFFORD AC , Burstein HJ, Barkley CR, Smith BL, et al
   Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival.
   Breast Cancer Res Treat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. SAXENA A , Dhillon VS, Raish M, Asim M, et al
    Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. DIGNAM JJ , Dukic VM
    Comments on: Yin W, Di G, Zhou L, Lu J, Liu G, Wu J, Shen K, Han Q, Shen Z, Shao Z. Time-varying pattern of recurrence risk for Chinese breast cancer patients.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles   
    
    
    
12. ZHANG X , Harrington N, Moraes RC, Wu MF, et al
    Cyclopamine inhibition of human breast cancer cell growth independent of Smoothened (Smo).
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. JOURNE F , Durbecq V, Chaboteaux C, Rouas G, et al
    Association between farnesoid X receptor expression and cell proliferation in estrogen receptor-positive luminal-like breast cancer from postmenopausal patients.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. YIN WJ , Lu JS, Di GH, Lin YP, et al
    Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
15. LOIZIDOU MA , Michael T, Neuhausen SL, Newbold RF, et al
    DNA-repair genetic polymorphisms and risk of breast cancer in Cyprus.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
16. HAN J , Haiman C, Niu T, Guo Q, et al
    Genetic variation in DNA repair pathway genes and premenopausal breast cancer risk.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
17. MAJED B , Moreau T, Asselain B
    Overweight, obesity and breast cancer prognosis: optimal body size indicator cut-points.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
18. FALLOWFIELD LJ
    Treatment decision-making in breast cancer: the patient-doctor relationship.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
19. PARTRIDGE AH , Wolff AC, Marcom PK, Kaufman PA, et al
    The impact of sharing results of a randomized breast cancer clinical trial with study participants.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
20. SPURDLE AB , Deans AJ, Duffy D, Goldgar DE, et al
    No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
21. DENT R , Hanna WM, Trudeau M, Rawlinson E, et al
    Pattern of metastatic spread in triple-negative breast cancer.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
22. REBBECK TR , Antoniou AC, Llopis TC, Nevanlinna H, et al
    No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. POTTER SM , Dwyer RM, Curran CE, Hennessy E, et al
    Systemic chemokine levels in breast cancer patients and their relationship with circulating menstrual hormones.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
24. LANZINO M , Garofalo C, Morelli C, Le Pera M, et al
    Insulin receptor substrate 1 modulates the transcriptional activity and the stability of androgen receptor in breast cancer cells.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
25. SIKORA MJ , Cordero KE, Larios JM, Johnson MD, et al
    The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
26. HARIGOPAL M , Heymann J, Ghosh S, Anagnostou V, et al
    Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
27. XU X , Gammon MD, Zhang Y, Bestor TH, et al
    BRCA1 promoter methylation is associated with increased mortality among women with breast cancer.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
28. JUSTENHOVEN C , Hamann U, Pierl CB, Baisch C, et al
    CYP2C19*17 is associated with decreased breast cancer risk.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    May 2008
29. YANG Q , Moran MS, Haffty BG
    Bcl-2 expression predicts local relapse for early-stage breast cancer receiving conserving surgery and radiotherapy.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
30. JACOBI CE , de Bock GH, Siegerink B, van Asperen CJ, et al
    Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose?
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
31. CHEN W , Pan K, Ouyang T, Li J, et al
    BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
32. HAN HS , Ro J, Lee KS, Nam BH, et al
    Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
33. ZHOU J , Zhang H, Gu P, Margolick JB, et al
    Cancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse model.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
34. PAL SK , Blazer K, Weitzel J, Somlo G, et al
    An association between invasive breast cancer and familial idiopathic hyperparathyroidism: a case series and review of the literature.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
35. BEYER SJ , Jimenez RE, Shapiro CL, Cho JY, et al
    Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer?
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
36. CAM R , Eroglu A, Egin Y, Akar N, et al
    Dihydrofolate reductase (DHRF) 19-bp intron-1 deletion and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms in breast cancer.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles   
    
    
    
37. DICKLER MN , Cobleigh MA, Miller KD, Klein PM, et al
    Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
38. HISCOX S , Jordan NJ, Smith C, James M, et al
    Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
39. VAN NES JG , Putter H, Julien JP, Tubiana-Hulin M, et al
    Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
40. FOUNTZILAS G , Dafni U, Dimopoulos MA, Koutras A, et al
    A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer : A Hellenic Cooperative Oncology Group study.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
41. CAO AY , Huang J, Hu Z, Li WF, et al
    Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
42. GINSBURG O , Ghadirian P, Lubinski J, Cybulski C, et al
    Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
43. JOHNATTY SE , Beesley J, Chen X, Hopper JL, et al
    The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case-control and family analysis.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
44. MU L , Katsaros D, Wiley A, Lu L, et al
    Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
45. SAADAT M , Ansari-Lari M
    Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
46. SPEIRS V , Shaaban AM
    The rising incidence of male breast cancer.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles   
    
    
    
47. AMAR S , Roy V, Perez EA
    Treatment of metastatic breast cancer: looking towards the future.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
48. CHIRIVELLA I , Bermejo B, Insa A, Perez-Fidalgo A, et al
    Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
49. TAO MH , Shields PG, Nie J, Millen A, et al
    DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
50. KIBRIYA MG , Jasmine F, Argos M, Andrulis IL, et al
    A pilot genome-wide association study of early-onset breast cancer.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
51. BEINER ME , Zhang WW, Zhang S, Gallinger S, et al
    Mutations of the MYH gene do not substantially contribute to the risk of breast cancer.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    April 2008
52. CAO AY , Huang J, Hu Z, Li WF, et al
    The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
53. AU HJ , Golmohammadi K, Younis T, Verma S, et al
    Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
54. PEREZ EA
    Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
55. TAO W , Wang C, Han R, Jiang H, et al
    HER2 codon 655 polymorphism and breast cancer risk: a meta-analysis.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
56. STAMBOLIC V , Woodgett JR, Fantus IG, Pritchard KI, et al
    Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles   
    
    
    
57. GOODWIN PJ , Ennis M, Bahl M, Fantus IG, et al
    High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
58. SCHEGERIN M , Tosteson AN, Kaufman PA, Paulsen KD, et al
    Prognostic imaging in neoadjuvant chemotherapy of locally-advanced breast cancer should be cost-effective.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
59. WELSH ML , Buist DS, Aiello Bowles EJ, Anderson ML, et al
    Population-based estimates of the relation between breast cancer risk, tumor subtype, and family history.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
60. COSTANTINO L , Catalano MG, Frairia R, Carmazzi CM, et al
    Molecular mechanisms of the D327N SHBG protective role on breast cancer development after estrogen exposure.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
61. BRAMWELL VH , Doig GS, Tuck AB, Wilson SM, et al
    Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
62. LEE SG , Jee YG, Chung HC, Kim SB, et al
    Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC).
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
63. YUVARAJ S , Premkumar VG, Shanthi P, Vijayasarathy K, et al
    Effect of Coenzyme Q(10), Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
64. PATANI N , Mokbel K
    The clinical significance of sentinel lymph node micrometastasis in breast cancer.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
65. YIN W , Di G, Zhou L, Lu J, et al
    Time-varying pattern of recurrence risk for Chinese breast cancer patients.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
66. HADAD SM , Appleyard V, Thompson AM
    Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles   
    
    
    
67. LU WL , Jansen L, Post WJ, Bonnema J, et al
    Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
68. ZHANG H , Sachdev D, Wang C, Hubel A, et al
    Detection and downregulation of type I IGF receptor expression by antibody-conjugated quantum dots in breast cancer cells.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
69. 
    30th Annual San Antonio Breast Cancer Symposium Late Breaking Abstracts.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles   
    
    
    
70. HENSLEY ALFORD S , Schwartz K, Soliman A, Johnson CC, et al
    Breast cancer characteristics at diagnosis and survival among Arab-American women compared to European- and African-American women.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
71. FROGNE T , Benjaminsen RV, Sonne-Hansen K, Sorensen BS, et al
    Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
72. KOHAAR I , Tiwari P, Kumar R, Nasare V, et al
    Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian population.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
73. LU W , Cui Y, Chen X, Zheng Y, et al
    Changes in quality of life among breast cancer patients three years post-diagnosis.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
74. JONES RJ , Young O, Renshaw L, Jacobs V, et al
    Src inhibitors in early breast cancer: a methodology, feasibility and variability study.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
75. MARQUES AR , Teixeira E, Diamond J, Correia H, et al
    Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
76. YEE KO , Connolly CM, Duquette M, Kazerounian S, et al
    The effect of thrombospondin-1 on breast cancer metastasis.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
77. CARRAWAY HE , Wang S, Blackford A, Guo M, et al
    Promoter hypermethylation in sentinel lymph nodes as a marker for breast cancer recurrence.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
78. PIERCE BL , Neuhouser ML, Wener MH, Bernstein L, et al
    Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
79. LACROIX M
    Poor usage of HUGO standard gene nomenclature in breast cancer studies.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles   
    
    
    
80. NKHATA KJ , Ray A, Dogan S, Grande JP, et al
    Mammary tumor development from T47-D human breast cancer cells in obese ovariectomized mice with and without estradiol supplements.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
81. COURNEYA KS , Friedenreich CM, Reid RD, Gelmon K, et al
    Predictors of follow-up exercise behavior 6 months after a randomized trial of exercise training during breast cancer chemotherapy.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
82. KELLEN E , Vansant G, Christiaens MR, Neven P, et al
    Lifestyle changes and breast cancer prognosis: a review.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
83. RICHARDS GM , Tome WA, Robins HI, Stewart JA, et al
    Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
84. NIEVES-ALICEA R , Colburn NH, Simeone AM, Tari AM, et al
    Programmed Cell Death 4 inhibits breast cancer cell invasion by increasing Tissue Inhibitor of Metalloproteinases-2 expression.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
85. RODER D , Houssami N, Farshid G, Gill G, et al
    Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia.
    Breast Cancer Res Treat. 2008;108:409-16.
    PubMed     Related articles    Abstract available
    
    
    
86. BEDARD PL , Freedman OC, Howell A, Clemons M, et al
    Overcoming endocrine resistance in breast cancer-are signal transduction inhibitors the answer?
    Breast Cancer Res Treat. 2008;108:307-17.
    PubMed     Related articles    Abstract available
    
    
    
87. STUTE P , Gotte M, Kiesel L
    Differential effect of hormone therapy on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro.
    Breast Cancer Res Treat. 2008;108:363-74.
    PubMed     Related articles    Abstract available
    
    
    March 2008
88. MENDIZABAL-RUIZ AP , Morales JA, Ramirez-Jirano LJ, Padilla-Rosas M, et al
    Low frequency of human papillomavirus DNA in breast cancer tissue.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
89. SKALAND I , Janssen EA, Gudlaugsson E, Klos J, et al
    Validating the prognostic value of proliferation measured by Phosphohistone H3 (PPH3) in invasive lymph node-negative breast cancer patients less than 71 years of age.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
90. CASEY T , Bond J, Tighe S, Hunter T, et al
    Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
91. AZIM HA JR , Bellettini G, Gelber S, Peccatori FA, et al
    Breast-feeding after breast cancer: if you wish, madam.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
92. PASZAT L , Sutradhar R, Grunfeld E, Gainford C, et al
    Outcomes of surveillance mammography after treatment of primary breast cancer: a population-based case series.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
93. HAN HS , Lee KW, Kim JH, Kim SW, et al
    Weight changes after adjuvant treatment in Korean women with early breast cancer.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
94. VAN AGTHOVEN T , Veldscholte J, Smid M, van Agthoven TL, et al
    Functional identification of genes causing estrogen independence of human breast cancer cells.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
95. WILDIERS H , Dirix L, Neven P, Prove A, et al
    Delivery of adjuvant sequential dose-dense FEC-Doc to patients with breast cancer is feasible, but dose reductions and toxicity are dependent on treatment sequence.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
96. DE VECCHI G , Verderio P, Pizzamiglio S, Manoukian S, et al
    Evidences for association of the CASP8 -652 6N del promoter polymorphism with age at diagnosis in familial breast cancer cases.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles   
    
    
    
97. ALANSARI AS , Al-Moundhri M, Al-Nabhani MM, Al-Zidjali SA, et al
    BRCA1 2080insA mutation in familial breast cancer.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles   
    
    
    
98. HE C , Tamimi RM, Hankinson SE, Hunter DJ, et al
    A prospective study of genetic polymorphism in MPO, antioxidant status, and breast cancer risk.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
99. RODY A , Karn T, Ruckhaberle E, Muller V, et al
    Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer.
    Breast Cancer Res Treat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
100. COUTANT C , Rouzier R, Fondrinier E, Marchal F, et al
     Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
101. SOILAND H , Janssen EA, Korner H, Varhaug JE, et al
     Apolipoprotein D predicts adverse outcome in women >/=70 years with operable breast cancer.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
102. CUST AE , Stocks T, Lukanova A, Lundin E, et al
     The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
103. GENTILINI O , Botteri E, Rotmensz N, Da Lima L, et al
     Conservative surgery in patients with multifocal/multicentric breast cancer.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
104. GOREY KM , Luginaah IN, Schwartz KL, Fung KY, et al
     Increased racial differences on breast cancer care and survival in America: historical evidence consistent with a health insurance hypothesis, 1975-2001.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
105. YEO W , Mo FK, Suen JJ, Ho WM, et al
     A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
106. HARVELL DM , Spoelstra NS, Singh M, McManaman JL, et al
     Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistance.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
107. DEHDASHTI F , Mortimer JE, Trinkaus K, Naughton MJ, et al
     PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
108. LANG JE , Mosalpuria K, Cristofanilli M, Krishnamurthy S, et al
     HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
109. RAKHA EA , El-Sayed ME, Reis-Filho J, Ellis IO, et al
     Patho-biological aspects of basal-like breast cancer.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
110. LUND MJ , Trivers KF, Porter PL, Coates RJ, et al
     Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
111. BUCCHI L , Foca F, Ravaioli A, Vattiato R, et al
     Receipt of adjuvant systemic therapy among patients with high-risk breast cancer detected by mammography screening.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
112. KOK M , Linn SC, Van Laar RK, Jansen MP, et al
     Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
113. MARTIN SE , Sausen M, Joseph A, Biggs DD, et al
     BRCA1 E1644X: a deleterious mutation in an African American individual with early onset breast cancer.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
114. VERKOOIJEN HM , Yap KP, Bhalla V, Chow KY, et al
     Multiparity and the risk of premenopausal breast cancer: different effects across ethnic groups in Singapore.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
115. KIKUMORI T , Kobayashi T, Sawaki M, Imai T, et al
     Anti-cancer effect of hyperthermia on breast cancer by magnetite nanoparticle-loaded anti-HER2 immunoliposomes.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
116. LU X , Lu X, Wang ZC, Iglehart JD, et al
     Predicting features of breast cancer with gene expression patterns.
     Breast Cancer Res Treat. 2008;108:191-201.
     PubMed     Related articles    Abstract available
     
     
     
117. BERG JC , Visscher DW, Vierkant RA, Pankratz VS, et al
     Breast cancer risk in women with radial scars in benign breast biopsies.
     Breast Cancer Res Treat. 2008;108:167-74.
     PubMed     Related articles    Abstract available
     
     
     
118. MCTIERNAN A , Wu L, Barnabei VM, Chen C, et al
     Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal women.
     Breast Cancer Res Treat. 2008;108:217-31.
     PubMed     Related articles    Abstract available
     
     
     
119. CHAVEZ-MACGREGOR M , van Gils CH, van der Schouw YT, Monninkhof E, et al
     Lifetime cumulative number of menstrual cycles and serum sex hormone levels in postmenopausal women.
     Breast Cancer Res Treat. 2008;108:101-12.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
120. GAO J , Warren R, Warren-Forward H, Forbes JF, et al
     Reproducibility of visual assessment on mammographic density.
     Breast Cancer Res Treat. 2008;108:121-7.
     PubMed     Related articles    Abstract available
     
     
     
121. STOFF-KHALILI MA , Rivera AA, Nedeljkovic-Kurepa A, DeBenedetti A, et al
     Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational control.
     Breast Cancer Res Treat. 2008;108:43-55.
     PubMed     Related articles    Abstract available
     
     
     
122. BYRSKI T , Gronwald J, Huzarski T, Grzybowska E, et al
     Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers.
     Breast Cancer Res Treat. 2008;108:289-96.
     PubMed     Related articles    Abstract available
     
     
     
123. LIU GY , Lu JS, Shen KW, Wu J, et al
     Fiberoptic ductoscopy combined with cytology testing in the patients of spontaneous nipple discharge.
     Breast Cancer Res Treat. 2008;108:271-7.
     PubMed     Related articles    Abstract available
     
     
     
124. LEFF DR , Warren OJ, Enfield LC, Gibson A, et al
     Diffuse optical imaging of the healthy and diseased breast: a systematic review.
     Breast Cancer Res Treat. 2008;108:9-22.
     PubMed     Related articles    Abstract available
     
     
     
125. OKARVI SM
     Evaluation of radiolabeled bombesin analogs in animals.
     Breast Cancer Res Treat. 2008;108:151.
     PubMed     Related articles   
     
     
     February 2008
126. AKBARI MR , Ghadirian P, Robidoux A, Foumani M, et al
     Germline RAP80 mutations and susceptibility to breast cancer.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
127. KIMMICK GG , Cirrincione C, Duggan DB, Bhalla K, et al
     Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944).
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
128. GARCIA MJ , Fernandez V, Osorio A, Barroso A, et al
     Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
129. MEIJER D , Jansen MP, Look MP, Ruigrok-Ritstier K, et al
     TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
130. MEESKE KA , Sullivan-Halley J, Smith AW, McTiernan A, et al
     Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
131. WASIELEWSKI M , Hanifi-Moghaddam P, Hollestelle A, Merajver SD, et al
     Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
132. HEMMINKI K , Forsti A, Lorenzo Bermejo J
     Surveying germline genomic landscape of breast cancer.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
133. LANGER I , Guller U, Berclaz G, Koechli OR, et al
     Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
134. MARKOVITCH O , Tepper R, Fishman A, Aviram R, et al
     Long-term "protective" effect of aromatase inhibitors on the endometrium of postmenopausal breast cancer patients.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
135. THOMASSEN M , Tan Q, Kruse TA
     Gene expression meta-analysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
136. MOHAMMED RA , Ellis IO, Elsheikh S, Paish EC, et al
     Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
137. BONOFIGLIO D , Gabriele S, Aquila S, Qi H, et al
     Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
138. CHRISTENSEN S , Zachariae R, Jensen AB, Vaeth M, et al
     Prevalence and risk of depressive symptoms 3-4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
139. LI LF , Xu XJ, Zhao Y, Liu ZB, et al
     Integrated gene expression profile predicts prognosis of breast cancer patients.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
140. LOWER EE , Glass E, Blau R, Harman S, et al
     HER-2/neu expression in primary and metastatic breast cancer.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
141. HOLM NT , Abreo F, Johnson LW, Li BD, et al
     Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC).
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
142. DAMSTRA RJ , Voesten HG, van Schelven WD, van der Lei B, et al
     Lymphatic venous anastomosis (LVA) for treatment of secondary arm lymphedema. A prospective study of 11 LVA procedures in 10 patients with breast cancer related lymphedema and a critical review of the literature.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
143. OSORIO A , Barroso A, Garcia MJ, Martinez-Delgado B, et al
     Evaluation of the BRCA1 interacting genes RAP80 and CCDC98 in familial breast cancer susceptibility.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
144. RAHMAN M , Davis SR, Pumphrey JG, Bao J, et al
     TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
145. GOLFINOPOULOSS V , Pentheroudakis G, Kamakari S, Metaxa-Mariatou V, et al
     Donor-derived breast cancer in a bone marrow transplantation recipient.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
146. THURLIMANN B , Price KN, Gelber RD, Holmberg SB, et al
     Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
147. PHOENIX KN , Vumbaca F, Claffey KP
     Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
148. SUBRAMANIAM MM , Chan JY, Soong R, Ito K, et al
     RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
149. AALTONEN K , Amini RM, Landberg G, Eerola H, et al
     Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
150. GUTIERREZ-ENRIQUEZ S , Balmana J, Baiget M, Diez O, et al
     Detection of the CHEK2 1100delC mutation by MLPA BRCA1/2 analysis: a worthwhile strategy for its clinical applicability in 1100delC low-frequency populations?
     Breast Cancer Res Treat. 2008;107:455-7.
     PubMed     Related articles   
     
     
     
151. MANFRIN E , Remo A, Falsirollo F, Reghellin D, et al
     Risk of neoplastic transformation in asymptomatic radial scar. Analysis of 117 cases.
     Breast Cancer Res Treat. 2008;107:371-7.
     PubMed     Related articles    Abstract available
     
     
     
152. GUSEVA NV , Rokhlin OW, Taghiyev AF, Cohen MB, et al
     Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L).
     Breast Cancer Res Treat. 2008;107:349-57.
     PubMed     Related articles    Abstract available
     
     
     
153. KONSTANTOPOULOU I , Rampias T, Ladopoulou A, Koutsodontis G, et al
     Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients.
     Breast Cancer Res Treat. 2008;107:431-41.
     PubMed     Related articles    Abstract available
     
     
     
154. STARK A , Kapke A, Schultz D, Brown R, et al
     Advanced stages and poorly differentiated grade are associated with an increased risk of HER2/neu positive breast carcinoma only in White women: findings from a prospective cohort study of African-American and White-American women.
     Breast Cancer Res Treat. 2008;107:405-14.
     PubMed     Related articles    Abstract available
     
     
     January 2008
155. COVELER AL , Goodell V, Webster DJ, Salazar LG, et al
     Common adjuvant breast cancer therapies do not inhibit cancer vaccine induced T cell immunity.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
156. AZAB SS , Salama SA, Abdel-Naim AB, Khalifa AE, et al
     2-Methoxyestradiol and multidrug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells?
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
157. SHIN A , Matthews CE, Shu XO, Gao YT, et al
     Joint effects of body size, energy intake, and physical activity on breast cancer risk.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
158. RUSSO A , Calo V, Bruno L, Schiro V, et al
     Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
159. CHOI YJ , Choi YL, Cho EY, Shin YK, et al
     Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
160. CLAR H , Krippl P, Renner W, Langsenlehner T, et al
     Association of polymorphisms of angiogenesis genes with breast cancer.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles   
     
     
     
161. LECOMTE J , Flament S, Salamone S, Boisbrun M, et al
     Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
162. KOTSOPOULOS J , Zhang WW, Zhang S, McCready D, et al
     Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
163. HAINES GK 3RD , Wiley E, Susnik B, Apple SK, et al
     HER2 in well differentiated breast cancer: is testing necessary?
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
164. GRONWALD J , Pijpe A, Byrski T, Huzarski T, et al
     Early radiation exposures and BRCA1-associated breast cancer in young women from Poland.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
165. CARDOSO MJ , Magalhaes A, Almeida T, Costa S, et al
     Is face-only photographic view enough for the aesthetic evaluation of breast cancer conservative treatment?
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
166. KAHAN Z , Spanik S, Wagnerova M, Skacel T, et al
     Feasibility of two dose-dense FEC regimens with growth factor support for adjuvant therapy in patients with early breast cancer: results from a randomised study of the Central European Cooperative Oncology Group (CECOG).
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
167. UEMATSU T , Yuen S, Kasami M, Uchida Y, et al
     Comparison of magnetic resonance imaging, multidetector row computed tomography, ultrasonography, and mammography for tumor extension of breast cancer.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
168. CAMERON D , Casey M, Press M, Lindquist D, et al
     A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
169. MUKAI H , Watanabe T, Ando M, Shimizu C, et al
     Assessment of different criteria for the pathological complete response (pCR) to primary chemotherapy in breast cancer: standardization is needed.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
170. LOIZIDOU MA , Michael T, Neuhausen SL, Newbold RF, et al
     Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
171. STANG A , Thomssen C
     Decline in breast cancer incidence in the United States: what about male breast cancer?
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles   
     
     
     
172. CHOI DH , Cho DY, Lee MH, Park HS, et al
     The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
173. QADIR MA , Kwok B, Dragowska WH, To KH, et al
     Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
174. IHNEN M , Muller V, Wirtz RM, Schroder C, et al
     Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
175. KLAR M , Jochmann A, Foeldi M, Stumpf M, et al
     The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population.
     Breast Cancer Res Treat. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
176. NAIK RP , Jin D, Chuang E, Gold EG, et al
     Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer.
     Breast Cancer Res Treat. 2008;107:133-8.
     PubMed     Related articles    Abstract available
     
     
     
177. YU CP , Yu JC, Sun CA, Tzao C, et al
     Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
     Breast Cancer Res Treat. 2008;107:95-102.
     PubMed     Related articles    Abstract available
     
     
     
178. TAKEI H , Suemasu K, Inoue K, Saito T, et al
     Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone receptor-positive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03).
     Breast Cancer Res Treat. 2008;107:87-94.
     PubMed     Related articles    Abstract available
     
     
     
179. KHOSHNOUD MR , Fornander T, Johansson H, Rutqvist LE, et al
     Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen.
     Breast Cancer Res Treat. 2008;107:71-8.
     PubMed     Related articles    Abstract available
     
     
     
180. BUCK MB , Coller JK, Murdter TE, Eichelbaum M, et al
     TGFbeta2 and TbetaRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cells.
     Breast Cancer Res Treat. 2008;107:15-24.
     PubMed     Related articles    Abstract available
     
     
     December 2007
181. BRAUN M , Flucke U, Debald M, Walgenbach-Bruenagel G, et al
     Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
182. NAKAYAMA S , Miyoshi Y, Ishihara H, Noguchi S, et al
     Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
183. KIM H , Chung H, Kim HJ, Lee JY, et al
     Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
184. MLINERITSCH B , Tausch C, Singer C, Luschin-Ebengreuth G, et al
     Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17).
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
185. ROSLIND A , Knoop AS, Jensen MB, Johansen JS, et al
     YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
186. SCHULZE EB , Hedley BD, Goodale D, Postenka CO, et al
     The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
187. XU H , Washington S, Verderame MF, Manni A, et al
     Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
188. JAWOROWSKA E , Serrano-Fernandez P, Tarnowska C, Lubinski J, et al
     Familial association of laryngeal, lung, stomach and early-onset breast cancer.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
189. WALKER LC , Waddell N, Ten Haaf A, Grimmond S, et al
     Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
190. GORRINGE KL , Choong DY, Lindeman GJ, Visvader JE, et al
     Breast cancer risk and the BRCA1 interacting protein CTIP.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
191. SEYMOUR IJ , Casadei S, Zampiga V, Rosato S, et al
     Results of a population-based screening for hereditary breast cancer in a region of North-Central Italy: contribution of BRCA1/2 germ-line mutations.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
192. CLAR H , Renner W, Krippl P, Leithner A, et al
     The LCT 13910 C/T polymorphism as a risk factor for osteoporosis, has no impact on metastatic bone disease in breast cancer.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles   
     
     
     
193. TAUCHER S , Steger GG, Jakesz R, Tausch C, et al
     The potential risk of neoadjuvant chemotherapy in breast cancer patients-results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07).
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
194. KONDO M , Hoshi SL, Ishiguro H, Yoshibayashi H, et al
     Economic evaluation of 21-gene reverse transcriptase-polymerase chain reaction assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer in Japan.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
195. GRAU AM , Wen W, Ramroopsingh DS, Gao YT, et al
     Circulating transforming growth factor-beta-1 and breast cancer prognosis: results from the Shanghai Breast Cancer Study.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
196. TKACZUK KH , Goloubeva O, Tait NS, Feldman F, et al
     The significance of circulating epithelial cells in Breast Cancer patients by a novel negative selection method.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
197. HOOGENDOORN WE , Hollema H, van Boven HH, Bergman E, et al
     Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
198. MINTON O , Stone P
     How common is fatigue in disease-free breast cancer survivors? A systematic review of the literature.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
199. NAVARI RM , Brenner MC, Wilson MN
     Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
200. DOMINGO-DOMENECH J , Pippa R, Tapia M, Gascon P, et al
     Inactivation of NF-kappaB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
201. CHUBAK J , Buist DS, Boudreau DM, Rossing MA, et al
     Breast cancer recurrence risk in relation to antidepressant use after diagnosis.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
202. RAJKUMAR T , Samson M, Rama R, Sridevi V, et al
     TGFbeta1 (Leu10Pro), p53 (Arg72Pro) can predict for increased risk for breast cancer in south Indian women and TGFbeta1 Pro (Leu10Pro) allele predicts response to neo-adjuvant chemo-radiotherapy.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
203. WAYNE SJ , Neuhouser ML, Ulrich CM, Koprowski C, et al
     Dietary fiber is associated with serum sex hormones and insulin-related peptides in postmenopausal breast cancer survivors.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
204. HARPUTLUOGLU H , Kara A, Dizdar O, Surmeli ZG, et al
     Prognostic factors in long-term breast cancer survivors with brain metastases.
     Breast Cancer Res Treat. 2007;.
     PubMed     Related articles   
     
     
     
205. DOWTY JG , Lose F, Jenkins MA, Chang JH, et al
     The RAD51D E233G variant and breast cancer risk: population-based and clinic-based family studies of Australian women.
     Breast Cancer Res Treat. 2007;.